Search results
Results From The WOW.Com Content Network
These cookies are necessary for the website to function. They are usually set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
Sign up today to receive the latest news and updates from UpToDate. Sign Up
Access UpToDate with Single Sign-On (SSO) using your email address or username for evidence-based clinical information.
Table of Contents. You have access to the entire UpToDate® library of specialties with your subscription. Click on one of the specialties below to see sections associated with each.
INTRODUCTION. Starting in the mid-20 th century, telemedicine programs began to emerge as a novel option to provide remote clinical examination and mental health support [].Since that time, the use of telemedicine, particularly video visits, has expanded to include telehealth and mobile health applications [].During the coronavirus disease 2019 (COVID-19) pandemic, the use of telemedicine ...
- Carboplatin plus docetaxel for adv non-small cell lung cancer - Carbo plus nabpaclitaxel advanced NSCLC - Carboplatin, paclitaxel, atezolizumab, and bevacizumab for NSCLC - Pemetrexed plus carboplatin for NSCLC and mesothelioma - Pemetrexed plus cisplatin NSCLC and meso regimen - Gemcitabine plus carboplatin for non-small cell lung cancer - Gemcitabine plus cisplatin regimen for NSCLC
Discover the latest updates in clinical practices with UpToDate's 'What's New' section, featuring evidence-based information for healthcare professionals.
INTRODUCTION. Cancer patients receiving systemic antineoplastic therapy sufficient to adversely affect myelopoiesis and the developmental integrity of the gastrointestinal mucosa are at risk for invasive infection due to colonizing bacteria and/or fungi that translocate across intestinal mucosal surfaces damaged by cytotoxic therapy.
Disclaimer: This generalized information is a limited summary of diagnosis, treatment, and/or medication information. It is not meant to be comprehensive and should be used as a tool to help the user understand and/or assess potential diagnostic and treatment options.
Learn about the benefits and harms of screening for prostate cancer with PSA test and other methods from UpToDate.